A, M. (2026). Immune checkpoint crosstalk between LAG-3 and CD39/CD73 in glioblastoma: Dual-pathway regulation of metabolic exhaustion and therapeutic reversal strategies. Journal of the Egyptian National Cancer Institute, 38(1), . https://doi.org/10.1186/s43046-026-00361-y
Chicago Style (17th ed.) CitationA, Mukherjee. "Immune Checkpoint Crosstalk Between LAG-3 and CD39/CD73 in Glioblastoma: Dual-pathway Regulation of Metabolic Exhaustion and Therapeutic Reversal Strategies." Journal of the Egyptian National Cancer Institute 38, no. 1 (2026). https://doi.org/10.1186/s43046-026-00361-y.
MLA (9th ed.) CitationA, Mukherjee. "Immune Checkpoint Crosstalk Between LAG-3 and CD39/CD73 in Glioblastoma: Dual-pathway Regulation of Metabolic Exhaustion and Therapeutic Reversal Strategies." Journal of the Egyptian National Cancer Institute, vol. 38, no. 1, 2026, https://doi.org/10.1186/s43046-026-00361-y.